These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 28344046

  • 1. Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
    Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N.
    Clin Lung Cancer; 2017 Sep; 18(5):565-571. PubMed ID: 28344046
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer.
    Zhang J, Gay HA, Russo S, Parent T, Aljumaily R, Walker PR.
    Lung Cancer; 2014 Jan; 83(1):67-72. PubMed ID: 24246506
    [Abstract] [Full Text] [Related]

  • 3. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L.
    J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.
    Salama JK, Stinchcombe TE, Gu L, Wang X, Morano K, Bogart JA, Crawford JC, Socinski MA, Blackstock AW, Vokes EE, Cancer and Leukemia Group B.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e269-74. PubMed ID: 21477940
    [Abstract] [Full Text] [Related]

  • 5. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A, Liptay M, LaCombe M, Marymont M, Kies MS, Sundaresan S, Masters G.
    Lung Cancer; 2004 Aug 15; 45(2):243-53. PubMed ID: 15246197
    [Abstract] [Full Text] [Related]

  • 6. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
    Arrieta O, Gallardo-Rincón D, Villarreal-Garza C, Michel RM, Astorga-Ramos AM, Martínez-Barrera L, de la Garza J.
    J Thorac Oncol; 2009 Jul 15; 4(7):845-52. PubMed ID: 19487963
    [Abstract] [Full Text] [Related]

  • 7. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W, Choy H.
    Lancet Oncol; 2015 Feb 15; 16(2):187-99. PubMed ID: 25601342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D, Neyns B, Fontaine C, Steene JV, De Mey J, Meysman M, De Grève J.
    Lung Cancer; 2007 May 15; 56(2):247-54. PubMed ID: 17337086
    [Abstract] [Full Text] [Related]

  • 10. Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.
    Kerner GS, van Dullemen LF, Wiegman EM, Widder J, Blokzijl E, Driever EM, van Putten JW, Liesker JJ, Renkema TE, Pieterman RM, Mertens MJ, Hiltermann TJ, Groen HJ.
    Radiat Oncol; 2014 Aug 29; 9():190. PubMed ID: 25174943
    [Abstract] [Full Text] [Related]

  • 11. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 29; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 12. A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
    Lim AM, Corry J, Collins M, Peters L, Hicks RJ, D'Costa I, Coleman A, Chua M, Solomon B, Rischin D.
    Oral Oncol; 2013 May 29; 49(5):468-74. PubMed ID: 23369852
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
    Choy H, Jain AK, Moughan J, Curran W, Whipple G, Demas WF, Ettinger DS.
    J Thorac Oncol; 2009 Jan 29; 4(1):80-6. PubMed ID: 19096311
    [Abstract] [Full Text] [Related]

  • 15. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
    Schallier D, Bral S, Ilsen B, Neyns B, Fontaine C, Decoster L, De Mey J, Meysman M, De Grève J.
    J Thorac Oncol; 2009 Jun 29; 4(6):728-35. PubMed ID: 19404217
    [Abstract] [Full Text] [Related]

  • 16. A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
    Banna GL, Lipari H, Nicolosi M, Basile A, Fraggetta F, Vaglica M, Marletta F, Urso OE, Ippolito M, Terminella A, Saita S.
    Med Oncol; 2013 Jun 29; 30(2):533. PubMed ID: 23512427
    [Abstract] [Full Text] [Related]

  • 17. Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.
    Kubota K, Kawahara M, Ogawara M, Nishiwaki Y, Komuta K, Minato K, Fujita Y, Teramukai S, Fukushima M, Furuse K, Japan Multi-National Trial Organisation.
    Lancet Oncol; 2008 Dec 29; 9(12):1135-42. PubMed ID: 19013107
    [Abstract] [Full Text] [Related]

  • 18. Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer.
    Sheng L, Cui X, Cheng L, Chen Y, Du X.
    Radiat Oncol; 2019 Dec 16; 14(1):229. PubMed ID: 31842910
    [Abstract] [Full Text] [Related]

  • 19. A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer.
    Treat J, Edelman MJ, Belani CP, Socinski MA, Monberg MJ, Chen R, Obasaju CK, Alpha Oncology Research Network.
    Lung Cancer; 2010 Dec 16; 70(3):340-6. PubMed ID: 20347506
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer.
    Bepler G, Dilling TJ, Wagner H, Hazelton T, Williams C, Chen DT, Greenberg H, Walsh F, Simon G, Tanvetyanon T, Chiappori A, Haura E, Stevens C.
    J Thorac Oncol; 2011 Mar 16; 6(3):553-8. PubMed ID: 21289520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.